TABLE 2.
Baseline laboratory parameters, imaging findings, and outcome of the seven PCR COVID‐19‐positive pediatric oncology cases receiving chemotherapy at NCI, Cairo University
No | Initial TLC109/L | Initial ANC109/L | Initial Ly109/L | Initial Plt109/L | Initial ALTU/L | Initial ASTU/L | Initial ferritinng/mL | Initial CRPmg/L | CT findings initially | CT progression | Time to negative PCR |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2500 | <100 | 2400 | 29 | 25 | 20 | 1443 | 19 | No | Yes | 5 weeks |
2 | 160 | <100 | 120 | 23 | 16 | 50 | >2000 | 268 | No | Yes | Persistently positive for 5 weeks |
3 | 480 | 150 | 270 | 15 | 51 | 60 | >2000 | 156 | No | No | 2 weeks |
4 | 2600 | <100 | 930 | 429 | 61 | 25 | 300 | 1 | No | No | 5 weeks |
5 | 3900 | 2800 | 440 | 74 | 6 | 25 | >2000 | 171 | Yes | Not evaluated | Persistently positive for 1 week |
6 | 1400 | 630 | 620 | 118 | 7 | 24 | 1338 | 220 | Yes | Yes | Persistently positive for 2 weeks |
7 | 1000 | 370 | 620 | 189 | 63 | 38 | NA | NA | No | No | 5 weeks |
Abbreviations: ALT, alanine aminotransferase; ANC, absolute neutrophil count; AST, aspartate aminotransferase; CT, computed topography; Ly, lymphocytes; NA, not available; Plt, platelet count; TLC, total leucocyte count.